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Methods and Results: We included prospectively the 42 consecutive
patients (younger than 75 yo) implanted in the University Hospital of Tou-
louse with ACC/AHA/ESC indications for CRT. Characteristics of the popu-
lation were: male sex 88%, ischemic cardiomyopathy 45%, mean  LVEF 22%,
mean QRS duration 160ms, CRT-D 98%. The echocardiographic (Pulsed
Doppler and Tissue Doppler Imaging) parameters of cardiac dysynchrony
were obtained at baseline and six month (or more) after CRT implant. We
defined the responder group as an improvement in 1 NYHA class and no hos-
pitalisation for heart failure (HF) during the follow up (mean duration 15
month). 62% (n=26) were clinical responders. The echocardiographic assess-
ment was done at 11 (6 to 20) month. There was no statistically significant
difference between the “residual” mechanical dysynchrony of the responders
versus the non-responders. Considering only the responders, there is no reduc-
tion of LIVD at six month after CRT. A baseline aortic pre-ejection delay >
140 ms, a non ischemic cardiomyopathy  and the left ventricular activation
time measured before implantation  with a method described recently by
Sweeney et al are the only factors of response to CRT.
Conclusions: The clinical response to CRT is not well correlate with the
“residual” mechanical LIVD such as we measured by echocardiography (DTI
and PD).
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Background: Cardiac Resynchronization Therapy (CRT) improves mor-
bidity and mortality in systolic heart failure. Elderly patients are under repre-
sented in large clinical trials although incidence of heart failure is high in this
population.
Method: we considered 146 consecutive patients  75 years old with stan-
dard indication for CRT implanted between 2005 and 2007. Mean age was 79
yo, 72 % males, EF= 27%, ischemic heart disease (IHD) 46%, Atrial Fibrilla-
tion 54%, CRT-D: 16%. Minimal follow-up was 12 months.  Total mortality,
clinical improvement (gain > 1 NYHA class without hospitalization for con-
gestive heart failure) and combined criteria (mortality and clinical improve-
ment) were retrospectively assessed.
Results: Mean follow-up is 25 +/-12 months. Data are complete for 137
patients (94.2%).
Survival rate is 65%, clinical improvement is achieved in 51% and combined
criteria in 45%.
Independent factors of non response (p<0.10) are summarized in the table.
Causes of deaths are: terminal heart failure: 35 pts, sudden cardiac death: 1 pt,
non cardiac death: 13 pts and unknown: 2 pts.
Conclusion: CRT is effective in elderly patients. Factors of non response
are similar to those observed in younger population. CRT-P appears to be the
most suitable device for this population.
(Voir tableau ci-dessous) 
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Objective: To assess whether LV mechanical dyssynchrony may be used
to predict response to CRT in patients with narrow QRS complex (<120ms).
Methods: CRT was performed in 183 symptomatic heart failure patients
(64±12 years, EF=25±8%) with narrow (n=41) and wide QRS complex
(n=142). Mechanical dyssynchrony before CRT implantation was quantified
by the 12 segment standard deviation of peak longitudinal strain by speckle
tracking (12SD) and the strain delay index (SDI) defined as the sum of differ-
ence between end systolic and peak strain across the 16 segments. 
Results: Before CRT, wide and narrow QRS patients had similar 12SD
(100±32ms vs. 105±35ms) and SDI (36±14% vs. 38±15%). However, in wide
QRS patients, QRS duration decreased after CRT (143±35ms vs. 120±34ms,
p<0.0001) and ESV reduction (mean= -21%, ESVR>15% in 66%, 92/139)
correlated with SDI (r=0.41, p<0.0001) and 12SD (r=0. 21, p=0.01) before
CRT. In contrast, in narrow QRS population, QRS duration increased after
CRT (96±16ms vs. 108±28ms, p=0.006) and ESV reduction (Mean=-11%,
ESVR>15% in 39% (25/41) failed to correlate with mechanical dyssynchrony
before CRT. Importantly, increase in QRS duration after CRT in narrow QRS
population was associated with adverse remodeling (r=0.43, p=0.01) and
tended to correlate with an increase in SDI after CRT (r=0.32, p=0.08). 
Conclusion: Response to CRT does not correlate to the importance of
mechanical dyssynchrony in narrow QRS population. The benefice of CRT
despite a significant LV dyssynchrony appears counterbalanced by a signifi-
cant QRS enlargement after CRT implantation in narrow QRS population. 
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Background: Cardiac resynchronisation therapy (CRT) has been shown to
improve clinical status in heart failure patients. Some patients treated by CRT
fail to respond to the treatment. Predisposing factors for non-response should
be investigated to optimize patient selection. 
Objective: The purpose of the study was to evaluate before device implan-
tation and 3, 6 and 12 month after, echocardiographic and biological parame-
ters with respect to  CRT response. 
Methods: Thirty two patients with heart failure (72% of men ; age 66 ± 10
years; 59 % non-ischaemic cardiomyopathy; NYHA III-IV; left ventricular
ejection fraction (LVEF) 22.7 ± 6.7 %; QRS width 146 ± 26 ms) were
implanted with CRT device and followed during twelve month. Responders
Multivariate analysis
OR (IC 95%)
Combined criteria Total
Mortality 
Clinical improvement
NYHA IV
IHD
CRT-D 
Atrial fibrillation
No ACEI /ARB
Renal failure ( creatinine > 10µm/l)
Doses of diuretics 
4,1 (1.5-12.4)
2,2 (1-4.8)
NS
2,7 (1.3-5.8)
2,7 (0.9-8.8)
1,1 (1-1.2)
NS
3.1 (1.2-8.5)
3.4 (1.5-7.9)
3.2 (1.2-8.8)
2.2 (1-5.1)
NS
NS
1.03 (1-1.1)
2.5 (1-6.6)
NS
NS
NS
NS
1.2 (1.1-1.3)
NS
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(R) were defined as patients with improvement of one or more NYHA func-
tional class, with a significant improvement in quality of life and without epi-
sode nor hospitalization for heart failure during follow-up.
Results:  34% of the patients constitute the non-responder group (NR). No
difference between R and NR was observed in LVEF, QRS width, NYHA,
cardiovascular risk factors nor drug medication. Non-ischaemic dilated cardi-
omyopathy was significantly more present in R (71% vs 27%; p=0.03). Before
CRT, NR had more important left ventricular end-diatolic diameter, left ven-
tricular end-systolic diameter  and  more elevated left pressions.  Atrioventric-
ular dyssynchrony was significantly more observed in R (66% vs 9%;
p=0.006) so as intraventricular dyssynchrony (95% vs 27%; p=0.001).BNP is
significantly more elevated in NR (602± 385 vs 320± 361; p=0.03) before
CRT.After 3 and 6 month, a significant decrease in left ventricular end-diatolic
and end-systolic diameters, LVEF and normalisation of left and right pressions
occur in R. Likewise,  BNP levels were lower in R.  
Conclusions: NR patients have before implantation a more severe cardi-
omyopathy. At follow-up, left ventricular remodelling could only be observed
in R patients. These data suggest that cardiac CRT should not be proposed too
late so that left ventricular remodelling could be expected.
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Background: Cardiac Resynchronization Therapy (CRT) is associated
with reverse left ventricular (LV) remodeling. However, the effects of CRT
induced mechanical remodeling on electrical remodeling, and the occurrence
of ventricular arrhythmias has not been clearly established.
Objectives: We studied the relationship between mechanical remodeling,
electrical remodeling and the occurrence of appropriate implantable cardio-
verter defibrillator (ICD) therapy one year after CRT.
Methods: We analyzed data from 45 patients who underwent ICD-CRT
implantation at our center. Patients had New York Heart Association (NYHA)
functional class III or IV heart failure symptoms, left ventricular ejection frac-
tion (LVEF) 35%, and QRS duration 120 ms or QRS <120ms with left intra-
ventricular dyssynchrony. Significant LV reverse remodeling was defined by
a minimum 10% decrease in the LV end diastolic diameter (LVEDd) at one
year of follow-up. Electrocardiographic indices of dispersion of repolarization
(DR) (QTc, Tpeak-Tend (Tp-e) and their dispersion) were measured immedi-
ately and one year post-CRT implantation. The occurrence of appropriate ICD
therapy was noted for each patient.
Results: Patients with (n=21) and without (n=24) significant LV reverse
remodeling had similar baseline characteristics. At one year of follow-up,
patients with reverse LV  remodeling exhibited both a significant decrease in
DR parameters and a lower rate of ICD therapy (p=0.0025).
Conclusion: Reverse LV mechanical remodeling is associated with
reversal of electrical remodeling and a lower rate of appropriate ICD therapy
following CRT.
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Introduction: post-ischemic electrical storm (PIES) occurring shortly after
the acute phase of myocardial infarction (MI) is a rare but potentially lethal
phenomenon. Clinical and therapeutic options are poorly known.  
Methods: 14 pts (12 men, 61 ± 13 years old) underwent RF ablation for
intractable PIES. PIES occurred 10 ± 5 days after MI (4 months in one pt).
Mean EF was 28 ± 7 %. Fast monomorphic VT (10 pts), FV (8 pts) or torsades
de pointes (5 pts) recurred in each pt despite maximal anti-arrhythmic therapy
(mean 22 ± 13 episodes). MI was inaugural anterior MI in each but 3 pts (sub-
endocardial in 2, inferior in 1), with one vessel disease (left descending artery)
in 8 pts (2 or 3 vessels in 6). When performed (4 pts), new PTCA did not con-
trol PIES. RF ablation was performed as a last chance solution, targetting ven-
tricular premature beats arising from the left septal Purkinje network (in all
patients the arrhythmia was of Purkinje origin, defined by a sharp spike
Purkinje-potential preceding ventricular activation during sinus rhythm as well
as during arrhythmia).
Results: Abolition of Purkinje potentials and of Purkinje premature beats
led to resumption of electrical storm in 12/14 pts with 1 procedure (2 in one
pt). The two pts with unsuccessful RF ablation died within a few hours from
intractable heart failure and recurring arrhythmias. All other pts were
implanted with an ICD (two pts had already been implanted before). During a
18 ± 19 months follow-up, 3 pts present with recurring isolated VT episodes
found in ICD memories. Seven pts died from cardiac or non cardiac causes (7
± 10 months).
Conclusions:  PIES is a rare but potentially lethal event occurring mainly
in inaugural large anterior acute MI. RF ablation of initiating Purkinje-prema-
ture beats may be an efficient therapeutic solution despite the poor long-term
prognosis of such patients.
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Introduction: Monomorphic sustained ventricular tachycardia (MSVT) in
structural heart disease (SHD) carries poor prognosis and usually needs ICD
implantation. Whether successful RF ablation of VT in this setting could avoid
the need of ICD implantation is largely unknown.
Methods: 105 successive with SHD (88 men, age 64 ± 16) were followed
after RF ablation of MSVT. An ICD was not implanted either because of end
stage extra cardiac pathology, advanced age or well-tolerated MSVT and pre-
served EF. 33 % were on amiodarone and 51 % on beta-blockers.
Results: 128 procedures were performed (1,2/pt) in 4 centers. Coronary
artery disease was present in 54%, right ventricular dysplasia in 10 %, dilated
cardiomyopathy in 10 % and various SHD in 26 %. Mean EF was 48 ± 12 %
(14 % with EF < 0,35). VT was well tolerated in 77 % (169 ± 32 bpm) with
syncope or near-syncope in 23 %. 11 % presented with electrical storm. Abla-
tion was performed using various techniques and end points. Complete acute
success was considered achieved in 80 % and undetermined in 5 pts. Not any
VT was induced in 92 % at the end of the procedure. Complications were arte-
rial dissection/occlusion (2 pts), tamponnade (1 pt), AV block (1 pt) and
hematomas (4 pts). Patients were discharged on beta-blockers (63%) and ami-
odarone (29%). Mean follow-up was 21 ± 16 months. VT recurred in 14 % (7
± 5 months) without compromise of the vital status. Mortality rate was 11 %
(no SD) (16 ± 15 months). Additional RF ablations were performed again in
14 pts with recurring VT and VT further recurred in 4 while SD occurred in
2.  Final VT recurrence rate including redo precedures was 14 %.  An ICD
was finally implanted in 5 pts. There was no difference in VT recurrence rate
according to the cardiopathy, clinical variables, EF, VT rate and tolerance or
to residual VT inducibility.
